Description: discussion of arbitrage possibilities cause by inconsistent mortality pricing assumptions in annuity products vis. a vis. life insurance products

Description: Presented at September 1994 Valuation Actuary Symposium. Discusses the differences in modeling separate account products vs. general account products.

Description: Discussion of a direct writer survey and a reinsurer survey conducted in the fall of 2002 by the Society of Actuaries. The surveys asked a number of questions about underwriting criteria needed to qualify for preferred risk. They also asked questions about the percentage of issues in each underwriting category and the mortality assumptions for the different categories.

Description: 1988 Valuation Actuary Symposium. The speakers in this session addressed the relative volatility of participating whole life versus universal life and the annual-premium versus single- premium basis.

Description: This article describes that some companies are ‘approaching the problem of how to accommodate Universal Life in GAAP statements by using a simple method which produces not unreasonable results and waiting for consensus on appropriate methodology to develop. This describes so of the methodology currently in use.

Description: This is an excel spreadsheet with some data pertaining to an article of the same name from the Product Development News

Description: Informative discussion about pricing techniques, including: [1] uses of return on investment [ROI], GAAP return on equity [ROE], and universal life [UL] and other profit measures, [2] scenario testing, [3] expenses, [4] target surplus, and [5] federal-income-tax considerations. From the 1988 Record of Society of Actuaries, Vol. 14, No. 2.

Description: This article discusses the proper slope of mortality tables, especially at the high attained ages.

Description: 1993 SOA Meeting, Quebec. The new SVL has expanded the scope and responsibilities of the valuation actuary. Topics covered: • Risk of legal liability for actuaries? • Vagueness of actuarial standards related to adequacy testing? • Reliance on other company experts? • Consultants versus company actuary perspectives? • The science versus the art of the process?

Description: This article is an extract from a revision to the Universal Life Study Note. From Product Development Section Monograph, M-AS99-3.